Header cover image
  • Investing Ideas
  • Dutch Pharmaceuticals & Biotech Top Stock Picks from Analysts

Dutch Pharmaceuticals & Biotech Top Stock Picks from Analysts

Results

1

0 new

Companies which are more than 50% undervalued based on analyst price target.

1 companies

Vivoryon Therapeutics

Market Cap: €33.2m

Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.

VVY

€1.12

7D

-8.9%

1Y

-21.0%